Multi-drug-resistant tuberculosis overview: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Multi-drug-resistant tuberculosis}} | {{Multi-drug-resistant tuberculosis}} | ||
{{CMG}} | {{CMG}}; {{AE}} {{AL}}; {{JS}}; {{Ammu}} | ||
==Overview== | ==Overview== | ||
'''Multi-drug resistant [[tuberculosis]]''' ('''MDR-TB''') is defined as TB that is resistant at least to [[isoniazid|isoniazid (INH)]] and [[rifampicin|rifampicin (RMP)]]. Isolates that are multiply-resistant to any other combination of anti-TB drugs but not to INH and RMP are not classed as MDR-TB. | '''Multi-drug resistant [[tuberculosis]]''' ('''MDR-TB''') is defined as TB that is resistant at least to [[isoniazid|isoniazid (INH)]] and [[rifampicin|rifampicin (RMP)]]. Isolates that are multiply-resistant to any other combination of anti-TB drugs but not to INH and RMP are not classed as MDR-TB. | ||
==Historical Perspective== | |||
==Classification== | |||
==Pathophysiology== | |||
==Causes== | |||
==Epidemiology and Demographics== | |||
==Risk Factors== | |||
==Screening== | |||
==Natural history, complications and prognosis== | |||
==Diagnosis== | |||
===History and Symptoms=== | |||
===Physical Examination=== | |||
===Laboratory findings=== | |||
===Electrocardiogram=== | |||
===Chest X-Ray=== | |||
===CT=== | |||
===MRI=== | |||
===Echocardiography or Ultrasound=== | |||
===Other Imaging findings=== | |||
===Other Diagnostic Studies=== | |||
==Treatment== | |||
===Medical Therapy=== | |||
====Special conditions==== | |||
====Drug-resistant==== | |||
====Children==== | |||
===Surgery=== | |||
=== Primary Prevention === | |||
===Secondary Prevention=== | |||
===Cost effectiveness of therapy=== | |||
===Future or investigational therapy=== | |||
==References== | ==References== | ||
{{ | {{Reflist|2}} | ||
[[Category:Bacterial diseases]] | |||
[[Category:Disease]] | |||
[[Category:Infectious disease]] | |||
[[Category:Pulmonology]] | |||
[[Category:Primary care]] | |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Revision as of 12:51, 29 September 2014
|
Multi-drug-resistant tuberculosis Microchapters |
|
Differentiating Multi-drug-resistant tuberculosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Multi-drug-resistant tuberculosis overview On the Web |
|
American Roentgen Ray Society Images of Multi-drug-resistant tuberculosis overview |
|
Directions to Hospitals Treating Multi-drug-resistant tuberculosis |
|
Risk calculators and risk factors for Multi-drug-resistant tuberculosis overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2]; João André Alves Silva, M.D. [3]; Ammu Susheela, M.D. [4]
Overview
Multi-drug resistant tuberculosis (MDR-TB) is defined as TB that is resistant at least to isoniazid (INH) and rifampicin (RMP). Isolates that are multiply-resistant to any other combination of anti-TB drugs but not to INH and RMP are not classed as MDR-TB.